Apellis Pharmaceuticals, Inc. revenue breakdown overview

Apellis Pharmaceuticals, Inc. revenue for the last year amounted to 781.37 M USD, the most of which — 781.37 M USD — came from its highest performing source at the moment, Novel Therapeutic Compounds, the year earlier bringing 396.59 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Apellis Pharmaceuticals, Inc. 709.95 M USD, and the year before that — 396.59 M USD.